Home-Based Transcutaneous Neuromodulation Improved Constipation via Modulating Gastrointestinal Hormones and Bile Acids

Table 3

(a) The Spearman correlation coefficient of the plasma gastrointestinal hormones and bile acids in FC patients before TN treatment (r-s, )

	5-HT		Motilin		VIP		Somatostatin
TDCA	−0.38	0.14	−0.05	0.86	0.09	0.72	−0.02	0.94
TCA	−0.26	0.32	0.01	0.98	0.21	0.42	−0.26	0.32
TLCA	−0.12	0.65	0.04	0.88	0.25	0.33	−0.13	0.63

; r-s, Spearman correlation coefficient.

(b) The Spearman correlation coefficient of the plasma gastrointestinal hormones and bile acids in FC patients after TN treatment (r-s, P)

	5-HT		Motilin		VIP		Somatostatin
TDCA	0.03	0.90	−0.19	0.46	−0.06	0.81	−0.05	0.85
TCA	−0.41	0.10	−0.29	0.25	0.20	0.44	0.41	0.10
TLCA	−0.23	0.37	−0.12	0.66	0.06	0.82	−0.19	0.46

; r-s, Spearman correlation coefficient.

(c) The Spearman correlation coefficient of the plasma gastrointestinal hormones and bile acids in healthy volunteers (r-s, P)

	5-HT		Motilin		VIP		Somatostatin
TDCA	−0.07	0.76	0.11	0.65	0.23	0.32	0.19	0.43
TCA	−0.33	0.15	−0.02	0.93	0.01	0.96	0.09	0.71
TLCA	−0.06	0.81	−0.10	0.69	0.06	0.80	−0.17	0.48

; r-s, Spearman correlation coefficient.